| Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised … B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro, ... The Lancet 394 (10212), 1915-1928, 2019 | 2269 | 2019 |
| Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open … V Subbiah, J Wolf, B Konda, H Kang, A Spira, J Weiss, M Takeda, Y Ohe, ... The Lancet Oncology 23 (10), 1261-1273, 2022 | 172 | 2022 |
| Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks AT Day, DJ Sher, RC Lee, JM Truelson, LL Myers, BD Sumer, L Stankova, ... Oral oncology 105, 104684, 2020 | 163 | 2020 |
| Immune dysregulation in cancer patients developing immune-related adverse events S Khan, SA Khan, X Luo, FJ Fattah, J Saltarski, Y Gloria-McCutchen, R Lu, ... British journal of cancer 120 (1), 63-68, 2019 | 152 | 2019 |
| Clinical practice in PET/CT for the management of head and neck squamous cell cancer R Goel, W Moore, B Sumer, S Khan, D Sher, RM Subramaniam American Journal of Roentgenology 209 (2), 289-303, 2017 | 138 | 2017 |
| ESMO/ASCO recommendations for a global curriculum in medical oncology edition 2016 C Dittrich, M Kosty, S Jezdic, D Pyle, R Berardi, J Bergh, N El-Saghir, ... ESMO open 1 (5), e000097, 2016 | 133 | 2016 |
| Prevalence of autoimmune disease among patients with lung cancer: implications for immunotherapy treatment options SA Khan, SL Pruitt, L Xuan, DE Gerber JAMA oncology 2 (11), 1507-1508, 2016 | 129 | 2016 |
| Comparative analysis of primary transmitter detection based spectrum sensing techniques in cognitive radio systems SA Malik, MA Shah, AH Dar, A Haq, AU Khan, T Javed, SA Khan Australian journal of basic and applied sciences 4 (9), 4522-4531, 2010 | 83 | 2010 |
| Pediatric, adolescent, and young adult thyroid carcinoma harbors frequent and diverse targetable genomic alterations, including kinase fusions P Vanden Borre, AB Schrock, PM Anderson, JC Morris III, AM Heilmann, ... The oncologist 22 (3), 255-263, 2017 | 69 | 2017 |
| A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG–ACRIN Cancer Research Group (E2511) TK Owonikoko, SE Dahlberg, SA Khan, DE Gerber, J Dowell, RA Moss, ... Lung Cancer 89 (1), 66-70, 2015 | 65 | 2015 |
| Comprehensive genomic profiling of clinically advanced medullary thyroid carcinoma AM Heilmann, V Subbiah, K Wang, JX Sun, JA Elvin, J Chmielecki, ... Oncology 90 (6), 339-346, 2016 | 52 | 2016 |
| An emerging framework for fully incorporating public involvement (PI) into patient-reported outcome measures (PROMs) J Carlton, T Peasgood, S Khan, R Barber, J Bostock, AD Keetharuth Journal of patient-reported outcomes 4, 1-10, 2020 | 46 | 2020 |
| Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients M Kobayashi, JS Chung, M Beg, Y Arriaga, U Verma, K Courtney, ... Clinical Cancer Research 25 (2), 828-838, 2019 | 46 | 2019 |
| Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study M Cauldwell, FL Mackie, PJ Steer, MA Henehghan, JH Baalman, ... BJOG: An International Journal of Obstetrics & Gynaecology 127 (7), 876-884, 2020 | 34 | 2020 |
| Preparation of substituted indoles by reduction of isatin and oxindole derivatives with diborane/tetrahydrofuran H Sirowej, SA Khan, H Plieninger Synthesis 84, 1972 | 32 | 1972 |
| Toxic effects of sorafenib in patients with differentiated thyroid carcinoma compared with other cancers GW Jean, RM Mani, A Jaffry, SA Khan JAMA oncology 2 (4), 529-534, 2016 | 29 | 2016 |
| Unique patterns of distant metastases in HPV-positive head and neck cancer R Sacks, JY Law, H Zhu, MS Beg, DE Gerber, BD Sumer, LL Myers, ... Oncology 98 (3), 179-185, 2020 | 28 | 2020 |
| Risk of unplanned hospital encounters in patients treated with radiotherapy for head and neck squamous cell carcinoma ZR Moore, NL Pham, JL Shah, L Nedzi, BD Sumer, AT Day, SA Khan, ... Journal of Pain and Symptom Management 57 (4), 738-745. e3, 2019 | 27 | 2019 |
| Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling SA Khan, B Ci, Y Xie, DE Gerber, MS Beg, SI Sherman, ME Cabanillas, ... Head & neck 41 (6), 1928-1934, 2019 | 22 | 2019 |
| Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study J Bendell, S Sharma, MR Patel, KS Windsor, ZA Wainberg, M Gordon, ... The oncologist 25 (11), 954-962, 2020 | 21 | 2020 |
